secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001493152-23-041662
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Director Edward Chan resigns from Interpace board; annual meeting results filed
-------------------------------------------------------------------------------

- Edward Chan resigned as Class II director effective Nov 15, 2023, not due to any disagreement.
- Annual meeting held Nov 14, 2023; stockholders elected Thomas W. Burnell and Joseph Keegan as Class III directors.
- Non-binding advisory vote on executive compensation approved with 9,177,922 for, 73,760 against.
- Ratification of EisnerAmper LLP as auditor for FY 2023 approved with 10,907,312 for, 42,734 against.
- Advisory vote on frequency of compensation votes: 9,089,392 voted for every three years (the board's recommendation).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315223041662/0001493152-23-041662-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315223041662/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-041662

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer